4-39300409-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002913.5(RFC1):​c.2541A>G​(p.Pro847Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.551 in 1,611,612 control chromosomes in the GnomAD database, including 253,413 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 18661 hom., cov: 32)
Exomes 𝑓: 0.56 ( 234752 hom. )

Consequence

RFC1
NM_002913.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.95

Publications

28 publications found
Variant links:
Genes affected
RFC1 (HGNC:9969): (replication factor C subunit 1) This gene encodes the large subunit of replication factor C, a five subunit DNA polymerase accessory protein, which is a DNA-dependent ATPase required for eukaryotic DNA replication and repair. The large subunit acts as an activator of DNA polymerases, binds to the 3' end of primers, and promotes coordinated synthesis of both strands. It may also have a role in telomere stability. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2011]
RFC1 Gene-Disease associations (from GenCC):
  • cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 4-39300409-T-C is Benign according to our data. Variant chr4-39300409-T-C is described in ClinVar as Benign. ClinVar VariationId is 1327949.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.95 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.617 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002913.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RFC1
NM_002913.5
MANE Select
c.2541A>Gp.Pro847Pro
synonymous
Exon 20 of 25NP_002904.3
RFC1
NM_001204747.2
c.2544A>Gp.Pro848Pro
synonymous
Exon 20 of 25NP_001191676.1
RFC1
NM_001363496.2
c.2466A>Gp.Pro822Pro
synonymous
Exon 19 of 24NP_001350425.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RFC1
ENST00000349703.7
TSL:1 MANE Select
c.2541A>Gp.Pro847Pro
synonymous
Exon 20 of 25ENSP00000261424.4
RFC1
ENST00000381897.5
TSL:1
c.2544A>Gp.Pro848Pro
synonymous
Exon 20 of 25ENSP00000371321.1
RFC1
ENST00000505077.1
TSL:4
n.473A>G
non_coding_transcript_exon
Exon 5 of 5

Frequencies

GnomAD3 genomes
AF:
0.454
AC:
68910
AN:
151892
Hom.:
18663
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.140
Gnomad AMI
AF:
0.541
Gnomad AMR
AF:
0.583
Gnomad ASJ
AF:
0.529
Gnomad EAS
AF:
0.636
Gnomad SAS
AF:
0.615
Gnomad FIN
AF:
0.545
Gnomad MID
AF:
0.563
Gnomad NFE
AF:
0.570
Gnomad OTH
AF:
0.484
GnomAD2 exomes
AF:
0.558
AC:
140006
AN:
250688
AF XY:
0.565
show subpopulations
Gnomad AFR exome
AF:
0.128
Gnomad AMR exome
AF:
0.660
Gnomad ASJ exome
AF:
0.532
Gnomad EAS exome
AF:
0.655
Gnomad FIN exome
AF:
0.548
Gnomad NFE exome
AF:
0.568
Gnomad OTH exome
AF:
0.564
GnomAD4 exome
AF:
0.562
AC:
819854
AN:
1459602
Hom.:
234752
Cov.:
36
AF XY:
0.564
AC XY:
409464
AN XY:
726176
show subpopulations
African (AFR)
AF:
0.123
AC:
4117
AN:
33396
American (AMR)
AF:
0.645
AC:
28810
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.539
AC:
14077
AN:
26120
East Asian (EAS)
AF:
0.644
AC:
25549
AN:
39690
South Asian (SAS)
AF:
0.593
AC:
51121
AN:
86164
European-Finnish (FIN)
AF:
0.554
AC:
29571
AN:
53408
Middle Eastern (MID)
AF:
0.521
AC:
2994
AN:
5746
European-Non Finnish (NFE)
AF:
0.568
AC:
631004
AN:
1110106
Other (OTH)
AF:
0.541
AC:
32611
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
16511
33021
49532
66042
82553
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17388
34776
52164
69552
86940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.453
AC:
68904
AN:
152010
Hom.:
18661
Cov.:
32
AF XY:
0.459
AC XY:
34083
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.139
AC:
5768
AN:
41468
American (AMR)
AF:
0.583
AC:
8909
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.529
AC:
1835
AN:
3470
East Asian (EAS)
AF:
0.635
AC:
3283
AN:
5170
South Asian (SAS)
AF:
0.615
AC:
2951
AN:
4800
European-Finnish (FIN)
AF:
0.545
AC:
5751
AN:
10560
Middle Eastern (MID)
AF:
0.551
AC:
162
AN:
294
European-Non Finnish (NFE)
AF:
0.570
AC:
38735
AN:
67954
Other (OTH)
AF:
0.483
AC:
1018
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1618
3237
4855
6474
8092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.526
Hom.:
34005
Bravo
AF:
0.441
Asia WGS
AF:
0.577
AC:
2009
AN:
3478
EpiCase
AF:
0.570
EpiControl
AF:
0.571

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

RFC1-related disorder Benign:1
Oct 30, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
3.5
DANN
Benign
0.59
PhyloP100
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066786; hg19: chr4-39302029; COSMIC: COSV62898407; COSMIC: COSV62898407; API